P01 CA 33049/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1987	1
1993	2
1996	1
1997	1
1998	3
1999	4
2000	1
2001	1
2002	1
2003	1
2004	1
2006	1
2015	1
2024	0

1

Targeted radiotherapy using Auger electron emitters.

O'Donoghue JA, Wheldon TE. O'Donoghue JA, et al. Phys Med Biol. 1996 Oct;41(10):1973-92. doi: 10.1088/0031-9155/41/10/009. Phys Med Biol. 1996. PMID: 8912375 Review.

2

Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemia.

Sgouros G, Graham MC, Divgi CR, Larson SM, Scheinberg DA. Sgouros G, et al. J Nucl Med. 1993 Mar;34(3):422-30. J Nucl Med. 1993. PMID: 8441034 Free article.

3

Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.

Jaggi JS, Seshan SV, McDevitt MR, Sgouros G, Hyjek E, Scheinberg DA. Jaggi JS, et al. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1503-12. doi: 10.1016/j.ijrobp.2005.11.036. Epub 2006 Feb 28. Int J Radiat Oncol Biol Phys. 2006. PMID: 16503385

4

PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.

Zanzonico P, Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, Humm JL, Smith-Jones P, Ruan S, Divgi C, Scott AM, Kemeny NE, Fong Y, Wong D, Scheinberg D, Ritter G, Jungbluth A, Old LJ, Larson SM. Zanzonico P, et al. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1700-1706. doi: 10.1007/s00259-015-3061-2. Epub 2015 Jul 21. Eur J Nucl Med Mol Imaging. 2015. PMID: 26194713 Free PMC article.

5

Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.

Sgouros G, Ballangrud AM, Jurcic JG, McDevitt MR, Humm JL, Erdi YE, Mehta BM, Finn RD, Larson SM, Scheinberg DA. Sgouros G, et al. J Nucl Med. 1999 Nov;40(11):1935-46. J Nucl Med. 1999. PMID: 10565792 Free article. Clinical Trial.

6

Implications of nonuniform tumor doses for radioimmunotherapy.

O'Donoghue JA. O'Donoghue JA. J Nucl Med. 1999 Aug;40(8):1337-41. J Nucl Med. 1999. PMID: 10450686 Free article.

7

Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3.

Ren S, Ariga T, Scarsdale JN, Zhang Y, Slominski A, Livingston PO, Ritter G, Kushi Y, Yu RK. Ren S, et al. J Lipid Res. 1993 Sep;34(9):1565-72. J Lipid Res. 1993. PMID: 8228639 Free article.

8

Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.

O'Donoghue JA, Sgouros G, Divgi CR, Humm JL. O'Donoghue JA, et al. J Nucl Med. 2000 Mar;41(3):538-47. J Nucl Med. 2000. PMID: 10716330 Free article.

9

Current status of antitumor therapy with monoclonal antibodies.

Scheinberg DA, Houghton AN. Scheinberg DA, et al. Oncology (Williston Park). 1987 May;1(3):31-40. Oncology (Williston Park). 1987. PMID: 3079479 Review.

10

Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy.

O'Donoghue JA, Baidoo N, Deland D, Welt S, Divgi CR, Sgouros G. O'Donoghue JA, et al. Cancer Biother Radiopharm. 2002 Aug;17(4):435-43. doi: 10.1089/108497802760363222. Cancer Biother Radiopharm. 2002. PMID: 12396707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year